AMGN Amgen Inc.
AMGN Amgen Inc.
Healthcare · Drug Manufacturers - General
Desk view
Market read
Scan convergence 3 scans as of 2026-10-16 3 bull converging
POC $344.32 · VWAP $358.94 · +20.5% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Cluster SVP + 2 others sold $4.1M, Aug 7–13
Coverage
5 watchlists
AMGN Price Structure
Loading timeframes…
Peers
Every watchlist AMGN belongs to, members best 30-day change first — AMGN highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@peptide-economy
@healthcare-scan
@healthcare
@ibb
@biotech-scan
Reported the quarter ending 2026-06-30: revenue $10.05B, diluted EPS $4.37, net income $2.38B (SEC filing, revenue corroborated by the desk's provider cache). Across the print the stock moved +7.6% (close before → first close after).
full note →Against street estimates
How AMGN's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
Recent news
Headlines about AMGN from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 10 days ago · Oct 7
AMGN research tape
155 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.